Home / Investors / Startups / Repertoire Immune Medicines

Repertoire Immune Medicines

Repertoire Immune Medicines is a clinical stage biotechnology company.

About Repertoire Immune Medicines

Repertoire Immune Medicines is a clinical stage biotechnology company working to unleash the human immune system to prevent, treat or cure cancer, autoimmune conditions and infectious diseases. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.

Industries

Investors in Repertoire Immune Medicines (4)